pelvic%20inflammatory%20disease
PELVIC INFLAMMATORY DISEASE
Pelvic inflammatory disease (PID) is the ascent of bacteria from the vagina or cervix resulting in infection of the reproductive organs eg uterus, fallopian tubes, ovaries. It may also be a complication of sexually transmitted infections.
The most common symptoms of PID are lower abdominal pain (crampy or dull) that usually starts a few days after the onset of the last menstrual period, dyspareunia, abnormal vaginal or cervical discharge, postcoital or irregular vaginal bleeding, dysuria, fever, nausea and vomiting, although some have minimal symptoms or silent pelvic inflammatory disease.

Follow Up

  • Further review 4 wk after treatment may be useful to ensure the following:
    • Adequate clinical response
    • Compliance w/ oral antibiotics
    • Screening & treatment of sex partners/contacts
    • Recurrence prevention through condom use
  • Repeat testing for etiologic organisms may be warranted for patients w/ persistent symptoms, poor compliance w/ antibiotics, or possible reinfection
    • In patients w/ documented infection w/ C trachomatis N gonorrhoeae, some specialists recommend rescreening 4-6 wk after completion of treatment

Counselling

  • STI consultation allows for an opportunity to discuss patient’s risk factors for STIs & HIV
  • Determine patient’s risk for HIV & discuss HIV testing
  • Testing for HIV is recommended & should be offered to all persons seeking evaluation & treatment for STIs
    • Pretest & posttest counseling as well as informed consent are part of the testing procedure
    • Concomitant infection w/ HIV may complicate management & control of some STIs
    • HIV-infected patients w/ PID are more common to have tubo-ovarian abscess & usually require surgical intervention
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
6 days ago
In pregnant women, adherence to recommended dietary intake of fat and fibre is associated with a more beneficial and richer gut microbiota which, in turn, decreases levels of the inflammation marker glycoprotein acetylation (GlycA), a study has shown.
4 days ago
Elagolix is safe and effective for reducing heavy menstrual bleeding in females with fibroids, a new dose-ranging, multiple-cohort study has shown.
13 Oct 2017
Dr Joon Kiong Lee discusses pharmacotherapy for osteoporosis and the role of FLS in fracture prevention
Tristan Manalac, 06 Oct 2017
In women with polycystic ovary syndrome (PCOS), combined oral contraceptive (COC) with spironolactone is more effective than metformin in reducing symptoms while showing a similar safety profile, according to a new randomized clinical trial (RCT).